BLAU3 · Blau Farmacêutica S.A. · Financials
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Revenue
1.7B
-3%
FY2025
Net Income
294.96M
+35.8%
FY2025
Gross Margin
40.1%
+2.6pp
FY2025
Operating Cash Flow
290.84M
-42.7%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| BRL | 1.82B | 1.7B | 1.75B | 1.37B | 1.41B | 1.37B | 1.18B | 977.5M | 782.17M | 617.66M |
| BRL | 1.05B | 1.02B | 1.1B | 882.38M | 739.03M | 700.47M | 625.84M | 547.44M | 443.91M | 337.22M |
| BRL | 764.39M | 682.74M | 658.75M | 490.25M | 667.88M | 665.93M | 555.97M | 430.07M | 338.26M | 280.43M |
| BRL | 249.2M | 388.47M | 291.89M | 334.23M | 468.56M | 482.47M | 353.64M | 286.36M | 178.4M | 148.49M |
| BRL | 51.03M | 91.7M | 78.36M | 86.74M | 108.07M | 158.6M | 99.31M | 86.13M | 55.15M | 45.36M |
| BRL | 198.9M | 294.96M | 217.21M | 249.81M | 360.49M | 325.22M | 254.33M | 200.24M | 123.25M | 103.13M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.